Economic Burden of Idiopathic Pulmonary Fibrosis: Updated Evidence on Costs and Resource Use

PharmacoEconomics 2026

View at publisher
Authors: Alexander Diamantopoulos, Oliver Pople, Antonia Godman, Evangelos Papastergios
DOI: 10.1007/s40273-026-01600-9
Cited by: 0
References: 91

Fields of Study & Subjects

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Health Systems Economic Evaluations Quality of Life Economic and Financial Impacts of Cancer

Publication details

Journal / source
PharmacoEconomics
Volume
44
Issue
6
Pages
665–703
Publication date
3 March 2026
Language
EN